Last Posted: Nov 14, 2019
- Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers.
Matsubayashi Hiroyuki et al. Diagnostics (Basel, Switzerland) 2019 Oct 9(4) - Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
Conley Claire C et al. Annals of surgical oncology 2019 Nov - Survey of primary care physicians' views about breast and ovarian cancer screening for true BRCA1/2 non-carriers.
Pelletier S et al. Journal of community genetics 2019 Oct - CMS Aims to Broaden Coverage for NGS Testing in Breast, Ovarian Cancer -Expansion would include patients with risk factors for inherited susceptibility mutations
I Ingram, MedPage Today, October 31, 2019 - Year in Review: Ovarian Cancer: PARP inhibitors, genetic testing, and novel combinations
I Ingram, Medpage Today, November 1, 2019 - Outcomes of women at high familial risk for breast cancer: An 8-year single-center experience.
Lammert Jacqueline et al. Asia-Pacific journal of clinical oncology 2019 Oct - 25 Years of BRCA: How a Cancer Milestone Has Changed the Field
J Infanti, Penn Medicine Blog, October 2019 - Angelina Jolie: Medical Advances in Women's Health Are Important. But They're Only Part of the Picture
A Jolie, Time, October 24, 2019 - Mapping genetic interactions in cancer: a road to rational combination therapies.
Tutuncuoglu Beril, et al. Genome medicine 2019 10 0. (1) 62 - BRCA1/2 Genetic Testing Recommendations Still Leave Issues Unresolved
U Penn Medicine, 2019
.png)
No hay comentarios:
Publicar un comentario